In a filing, Seres Therapeutics Inc revealed its CEO and President Shaff Eric D. unloaded Company’s shares for reported $12473.0 on Feb 16 ’24. In the deal valued at $1.08 per share,11,549 shares were sold. As a result of this transaction, Shaff Eric D. now holds 135,321 shares worth roughly $96077.90999999999.
Then, Ege David S. sold 5,010 shares, generating $5,411 in total proceeds. Upon selling the shares at $1.08, the insider now owns 73,856 shares.
Before that, von Moltke Lisa sold 4,400 shares. Seres Therapeutics Inc shares valued at $4,752 were divested by the insider at a price of $1.08 per share. As a result of the transaction, von Moltke Lisa now holds 16,988 shares, worth roughly $12061.48.
A number of analysts have revised their coverage, including JP Morgan’s analysts, who began to cover the stock in late April with a ‘”a Neutral”‘ rating. Goldman also remained covering MCRB and has decreased its forecast on July 23, 2021 with a “Sell” recommendation from previously “Neutral” rating.
Price Performance Review of MCRB
On Tuesday, Seres Therapeutics Inc [NASDAQ:MCRB] saw its stock fall -3.14% to $0.71. Over the last five days, the stock has lost -7.00%. Seres Therapeutics Inc shares have fallen nearly -49.33% since the year began. Nevertheless, the stocks have fallen -87.71% over the past one year. While a 52-week high of $6.87 was reached on 01/09/24, a 52-week low of $0.71 was recorded on 04/09/24. SMA at 50 days reached $0.9602, while 200 days put it at $2.1217. A total of 6.95 million shares were traded, compared to the trading of 4.33 million shares in the previous session.
Levels Of Support And Resistance For MCRB Stock
The 24-hour chart illustrates a support level at 0.6814, which if violated will result in even more drops to 0.6534. On the upside, there is a resistance level at 0.7426. A further resistance level may holdings at 0.7758. The Relative Strength Index (RSI) on the 14-day chart is 33.93, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0298, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 84.90%. Stochastics %K at 22.30% indicates the stock is a holding.
How much short interest is there in Seres Therapeutics Inc?
A steep rise in short interest was recorded in Seres Therapeutics Inc stocks on Mar 15, 2024, growing by 2.81 million shares to a total of 18.4 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 15.59 million shares. There was a rise of 15.27%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 17.06% of the overall stock float, the days-to-cover ratio (short ratio) rose to 3.79.
